“…Furthermore, the knockdown of RORα prevented the augmentation of FGF21 and up-regulation of CHOP in response to baicalein in C2C12 cells. Collectively, these results suggest that baicalein stimulates the ER stress response and FGF21 expression through a RORα-dependent mechanism in C2C12 myotubes, and indicates the potential of baicalein as an effective anti-obesity therapy via its ability to enhance FGF21 production (Hirai et al, 2019). Other reports have shown that the hepatic expression of FGF21 is either regulated positively or negatively by glucocorticoid receptor (GR) (Patel et al, 2015), cAMP-responsive element-binding protein H (CREBH) (Lee et al, 2017), carbohydrate response element-binding protein (ChREBP) (Iizuka et al, 2009), PPARγ (Moyers et al, 2007; Wang et al, 2008), farnesoid X receptor (FXR) (Cyphert et al, 2012), and liver X receptor (LXR) (Archer et al, 2012; Uebanso et al, 2012) under various conditions.…”